YIH
PCVX icon

Y-Intercept (HK)’s Vaxcyte PCVX Stock Holding History

Y-Intercept (HK)’s Portfolio PCVX Stock Details PCVX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-73,283
Closed -$2.64M – 1892
2025
Q3 		$2.64M Buy
+73,283
New +$2.43M 0.06% 460
2024
Q4 		– Sell
-26,019
Closed -$2.97M – 1542
2024
Q3 		$2.97M Buy
26,019
+15,556
+149% +$1.4M 0.18% 124
2024
Q2 		$790K Buy
+10,463
New +$712K 0.04% 600
2024
Q1 		– Sell
-12,859
Closed -$808K – 1662
2023
Q4 		$808K Buy
+12,859
New +$668K 0.08% 398

Other funds holding PCVX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return

Y-Intercept (HK)'s PCVX Position: Q4 2025 in Review

Y-Intercept (HK) sold out of Vaxcyte (PCVX) in Q4 2025, closing a stake of 73,283 shares — an estimated $2.64M sold.

Y-Intercept (HK) first reported a position in PCVX in Q4 2023 and held it in 4 quarters. The position peaked at $2.97M in Q3 2024. 295 funds tracked by Wall St. Rank hold PCVX as of Q4 2025.

  • Y-Intercept (HK) reported no remaining Vaxcyte position as of Q4 2025 after selling out during the quarter.
  • Y-Intercept (HK) sold 73,283 Vaxcyte shares in Q4 2025, an estimated $2.64M.
  • Y-Intercept (HK) first reported a position in Vaxcyte in Q4 2023 and held it in 4 quarters.
  • Y-Intercept (HK)'s Vaxcyte position peaked at $2.97M in Q3 2024.
  • 295 funds tracked by Wall St. Rank held Vaxcyte as of Q4 2025.

Based on Y-Intercept (HK)'s 13F filing for Q4 2025, filed 13 Feb 2026.